Roberto Cauda

20.9k citations
431 papers · 17.1k · 3 hit papers · h-index 63

Impact in

    • Antibiotic Resistance in Bacteria
    • COVID-19 Clinical Research Studies
    • HIV/AIDS drug development and treatment
    • Antifungal resistance and susceptibility
    • SARS-CoV-2 and COVID-19 Research
    • Antimicrobial Resistance in Staphylococcus

Papers in

    • HIV/AIDS drug development and treatment 63
    • Antifungal resistance and susceptibility 27
    • SARS-CoV-2 and COVID-19 Research 19
    • COVID-19 Clinical Research Studies 17
    • HIV Research and Treatment 28

Roberto Cauda

422 papers receiving 16.4k citations

Roberto Cauda's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+7+15Years since publication2505007501000

Peers

Roberto Cauda
Comparison fields: 5 of 133
  • Molecular Medicine 2.9k
  • Infectious Diseases 5.3k
  • Applied Microbiology and Biotechnology 459
  • Virology 800
  • Emergency Medicine 352
Replace Pierluigi Viale with:
Pierluigi Viale Italy
Shan‐Chwen Chang Taiwan
Mario Tumbarello Italy
Nicola Petrosillo Italy
Claudio Viscoli Italy
Menno Douwe de Jong Netherlands
Jun Yong Choi South Korea
Myoung‐don Oh South Korea
Robert A. Salata United States
Àlex Soriano Spain
Roberto Cauda relative to Pierluigi Viale Italy Pierluigi Viale's profile →
Citations per field
00.5×2×4×6×7.5×
Pierluigi Viale · 1×
Citations per year

Countries citing papers authored by Roberto Cauda

Since Specialization
Citations

This map shows the geographic impact of Roberto Cauda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Cauda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Cauda more than expected).

Fields of papers citing papers by Roberto Cauda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Cauda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Cauda. The network helps show where Roberto Cauda may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Cauda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Cauda Line = papers co-authored together Roberto Cauda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 431 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of chloroquine on viral infections: an old drug against today's diseases
Hit paper breakdown →
20031025
2
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Hit paper breakdown →
2012864
3 2015453
4 2006452
5 1996416
6 2007383
7 2007350
8 2018323
9 2007297
10
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
11 2006234
12 2021234
13 2014224
14 2011210
15 2020193
16 1999179
17 2010175
18 2012175
19 2006174
20 2002171

About Roberto Cauda

Roberto Cauda is a scholar working on Infectious Diseases, Virology, Molecular Medicine, Applied Microbiology and Biotechnology and Emergency Medicine, having authored 431 papers that have together received 17.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (63 papers), HIV Research and Treatment (28 papers), Antibiotic Resistance in Bacteria (28 papers), Antifungal resistance and susceptibility (27 papers), SARS-CoV-2 and COVID-19 Research (19 papers), HIV-related health complications and treatments (17 papers), COVID-19 Clinical Research Studies (17 papers) and Antibiotic Use and Resistance (15 papers). The work is most often cited by research in Molecular Medicine (2.9k citations), Infectious Diseases (5.3k citations), Applied Microbiology and Biotechnology (459 citations), Virology (800 citations) and Emergency Medicine (352 citations). Roberto Cauda has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Mario Tumbarello, Antonio Cassone, Evelina Tacconelli, Andrea Savarino, Enrico Maria Trecarichi, Teresa Spanu, Simona Di Giambenedetto, J R Boelaert, Andrea De Luca and Giovanni Fadda. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Infection, Antiviral Therapy and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact